BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Francesco VD, Ierardi E, Hassan C, Zullo A. Furazolidone therapy for Helicobacter pylori: Is it effective and safe? World J Gastroenterol 2009; 15(15): 1914-1915 [PMID: 19370795 DOI: 10.3748/wjg.15.1914]
URL: https://www.wjgnet.com/1007-9327/full/v15/i15/1914.htm
Number Citing Articles
1
C. Chiesa, L. Pacifico, C. Anania, E. Poggiogalle, F. Chiarelli, J.F. Osborn. Helicobacter Pylori Therapy in Children: Overview and ChallengesInternational Journal of Immunopathology and Pharmacology 2010; 23(2): 405 doi: 10.1177/039463201002300203
2
Rahim Raoufi Jahromi, Jamal Mirzaei, Jalil Rajabi, Seyed Javad Hoseini Shokouh, Taraneh Liaghat. Furazolidone-Based Quadruple Therapy for Eradication of Helicobacter pylori Infection in Peptic Ulcer DiseaseArchives of Clinical Infectious Diseases 2014; 9(3) doi: 10.5812/archcid.18549
3
Sotirios Georgopoulos, Vasilios Papastergiou. An update on current and advancing pharmacotherapy options for the treatment of H. pylori infectionExpert Opinion on Pharmacotherapy 2021; 22(6): 729 doi: 10.1080/14656566.2020.1845649
4
Ya-Wen Zhang, Wei-Ling Hu, Yuan Cai, Wen-Fang Zheng, Qin Du, John J Kim, John Y Kao, Ning Dai, Jian-Min Si. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for <i>Helicobacter pylori</i> infection and predictors of failed eradicationWorld Journal of Gastroenterology 2018; 24(40): 4596-4605 doi: 10.3748/wjg.v24.i40.4596
5
Hidekazu Suzuki, Toshihiro Nishizawa, Toshifumi Hibi. Helicobacter Pylori Eradication Therapy Future Microbiology 2010; 5(4): 639 doi: 10.2217/fmb.10.25
6
Current awareness: Pharmacoepidemiology and drug safetyPharmacoepidemiology and Drug Safety 2009; 18(11) doi: 10.1002/pds.1654
7
Javier P. Gisbert. Review: Second-line rescue therapy of Helicobacter pylori infectionTherapeutic Advances in Gastroenterology 2009; 2(6): 331 doi: 10.1177/1756283X09347109
8
Keerthika Devi Ramadhass, Muthusankar Ganesan, Tse-Wei Chen, Shen-Ming Chen, Qingli Hao, Wu Lei, Gopu Gopalakrishnan. Porous-coral-like cerium doped tungsten oxide/graphene oxide micro balls: A robust electrochemical sensing platform for the detection of antibiotic residueColloids and Surfaces A: Physicochemical and Engineering Aspects 2021; 628: 127275 doi: 10.1016/j.colsurfa.2021.127275
9
Jiali Zhang, Chunling Rong, Chenyang Yan, Jie Chen, Wenjun Yang, Lingyan Yu, Haibin Dai, Muhammad Shahzad Aslam. Risk factors of furazolidone-associated feverPLOS ONE 2022; 17(4): e0266763 doi: 10.1371/journal.pone.0266763
10
Hansa Y. Magee, Megan M. Maurer, April Cobos, Benny F.G. Pycke, Arjun K. Venkatesan, Daniel Magee, Matthew Scotch, Rolf U. Halden. U.S. nationwide reconnaissance of ten infrequently monitored antibiotics in municipal biosolidsScience of The Total Environment 2018; 643: 460 doi: 10.1016/j.scitotenv.2018.06.206
11
Shivaram Prasad Singh, Vineet Ahuja, Uday C. Ghoshal, Govind Makharia, Usha Dutta, Showkat Ali Zargar, Jayanthi Venkataraman, Amit Kumar Dutta, Asish K Mukhopadhyay, Ayaskanta Singh, Babu Ram Thapa, Kim Vaiphei, Malathi Sathiyasekaran, Manoj K. Sahu, Niranjan Rout, Philip Abraham, Prakash Chandra Dalai, Pravin Rathi, Saroj K. Sinha, Shobna Bhatia, Susama Patra, Ujjala Ghoshal, Ujjal Poddar, Venigalla Pratap Mouli, Vikram Kate. Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of GastroenterologyIndian Journal of Gastroenterology 2021; 40(4): 420 doi: 10.1007/s12664-021-01186-4
12
Jay Luther, William D. Chey, Richard J. Saad. A Clinician's Guide to Salvage Therapy for PersistentHelicobacter pyloriInfectionHospital Practice 2011; 39(1): 133 doi: 10.3810/hp.2011.02.383
13
Kláudia Maria Machado Neves Silva, Diogo Émerson Leite de Carvalho, Vânia Maria Moreira Valente, Juan Carlos Campos Rubio, Paulo Eustáquio Faria, Priscila Pereira Silva-Caldeira. Concomitant and controlled release of furazolidone and bismuth(III) incorporated in a cross-linked sodium alginate-carboxymethyl cellulose hydrogelInternational Journal of Biological Macromolecules 2019; 126: 359 doi: 10.1016/j.ijbiomac.2018.12.136
14
Javier P. Gisbert, Javier Molina-Infante, Alicia C. Marin, Gemma Vinagre, Jesus Barrio, Adrian Gerald McNicholl. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple “sequential” or “concomitant” treatment to eradicateH. pyloriinfectionScandinavian Journal of Gastroenterology 2013; 48(6): 652 doi: 10.3109/00365521.2013.786132
15
Lyudmila Boyanova, Ivan Mitov. Geographic map and evolution of primaryHelicobacter pyloriresistance to antibacterial agentsExpert Review of Anti-infective Therapy 2010; 8(1): 59 doi: 10.1586/eri.09.113
16
Yanhui Yu, Jing Xue, Fangbing Lin, Daming Liu, Wen Zhang, Shuying Ru, Feng Jiang. Global Primary Antibiotic Resistance Rate of Helicobacter pylori in Recent 10 years: A Systematic Review and Meta‐AnalysisHelicobacter 2024; 29(3) doi: 10.1111/hel.13103